<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item><item key="name">Children's Oncology Group Study 9906 for High-Risk Pediatric ALL</item><item key="sample_count">207</item><item key="tags"><item>acute lymphoblastic leukemia</item><item>cancer</item><item>disease</item><item>intermediate</item><item>leukemia</item><item>lymphoblastic leukemia</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-11877</item><item key="id">2897</item><item key="slug">childrens-oncology-group-study-9906-for-high-risk</item><item key="factor_count">18</item></item><item><item key="name">Chromatin H3K27me3/H3K4me3 histone marks define gene sets in high grade serous ovarian cancer that distinguish malignant, tumour sustaining and chemo-resistant ovarian tumour cells.</item><item key="sample_count">9</item><item key="tags"><item>cancer</item><item>cell</item><item>ovarian cancer</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-41500</item><item key="id">4594</item><item key="slug">chromatin-h3k27me3h3k4me3-histone-marks-define-gen</item><item key="factor_count">4</item></item><item><item key="name">Chromatin immunoprecipitation profiling of human breast cancer cell lines and tissues to identify novel estrogen receptor-{alpha} binding sites and estradiol target genes</item><item key="sample_count">9</item><item key="tags"><item>breast</item><item>breast cancer</item><item>cancer</item><item>cell</item><item>chromatin</item><item>disease</item><item>estrogen</item><item>genome</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-11506</item><item key="id">2877</item><item key="slug">chromatin-immunoprecipitation-profiling-of-human-b</item><item key="factor_count">0</item></item><item><item key="name">Clinical, Molecular and Genetic Validation of a Murine Orthotopic Xenograft Model of Pancreatic Adenocarcinoma using Fresh Human Specimens</item><item key="sample_count">47</item><item key="tags"><item>adenocarcinoma</item><item>cancer</item><item>cell</item><item>cytokine</item><item>disease</item><item>ductal adenocarcinoma</item><item>liver</item><item>pancreatic adenocarcinoma</item><item>pancreatic cancer</item><item>pancreatic ductal adenocarcinoma</item><item>tyrosine</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-46385</item><item key="id">2267</item><item key="slug">clinical-molecular-and-genetic-validation-of-a-mur</item><item key="factor_count">7</item></item><item><item key="name">COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.</item><item key="sample_count">60</item><item key="tags"><item>cancer</item><item>cell</item><item>collagen</item><item>disease</item><item>ovarian cancer</item><item>protein</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-44104</item><item key="id">2159</item><item key="slug">col11a1-promotes-tumor-progression-and-predicts-po</item><item key="factor_count">4</item></item><item><item key="name">Colorectal cancer classification based on gene expression is not associated with FOLFIRI response</item><item key="sample_count">11</item><item key="tags"><item>cancer</item><item>colorectal cancer</item><item>enterocyte</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-54483</item><item key="id">4728</item><item key="slug">colorectal-cancer-classification-based-on-gene-exp</item><item key="factor_count">0</item></item><item><item key="name">Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer &#160;</item><item key="sample_count">93</item><item key="tags"><item>bladder cancer</item><item>cancer</item><item>carcinoma</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-31684</item><item key="id">4218</item><item key="slug">combination-of-a-novel-gene-expression-signature-w</item><item key="factor_count">17</item></item><item><item key="name">Comparative gene expression analysis of mesenchymal stem cells (MSC) derived  from non-small cell lung cancer (NSCLC) and corresponding normal lung tissue (NLT)</item><item key="sample_count">10</item><item key="tags"><item>cancer</item><item>lung</item><item>nsclc</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-23066</item><item key="id">2547</item><item key="slug">comparative-gene-expression-analysis-of-mesenchyma</item><item key="factor_count">2</item></item><item><item key="name">Comparison of gene expression between CD133+ and CD133- SW620 human colon cancer cells</item><item key="sample_count">4</item><item key="tags"><item>cancer</item><item>cell</item><item>colon</item><item>colon cancer</item><item>line</item><item>stem cell</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-23295</item><item key="id">3760</item><item key="slug">comparison-of-gene-expression-between-cd133-and-cd</item><item key="factor_count">1</item></item><item><item key="name">Comparison of gene expression profiles of HT29 cells treated with Instant Caffeinated Coffee or Caffeic Acid versus control.</item><item key="sample_count">9</item><item key="tags"><item>breast</item><item>breast cancer</item><item>cancer</item><item>colon</item><item>colon cancer</item><item>disease</item><item>genome</item><item>protein</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-35382</item><item key="id">2425</item><item key="slug">comparison-of-gene-expression-profiles-of-ht29-cel</item><item key="factor_count">2</item></item></data></biogps>
